Eugénio Teófilo

1.0k total citations
22 papers, 319 citations indexed

About

Eugénio Teófilo is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Eugénio Teófilo has authored 22 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 10 papers in Virology and 6 papers in Emergency Medicine. Recurrent topics in Eugénio Teófilo's work include HIV/AIDS drug development and treatment (13 papers), HIV/AIDS Research and Interventions (11 papers) and HIV Research and Treatment (10 papers). Eugénio Teófilo is often cited by papers focused on HIV/AIDS drug development and treatment (13 papers), HIV/AIDS Research and Interventions (11 papers) and HIV Research and Treatment (10 papers). Eugénio Teófilo collaborates with scholars based in Portugal, Spain and Germany. Eugénio Teófilo's co-authors include Tab Bonny, Jaime E. Hernández, Trevor R. Scott, Cynthia H. Brothers, E. Randall Lanier, Jan Gerstoft, Edwin DeJesus, Ricardo Camacho, Judith Millard and Robin Wood and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Revista de Saúde Pública.

In The Last Decade

Eugénio Teófilo

21 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugénio Teófilo Portugal 9 254 178 74 63 31 22 319
Cassidy Henegar United States 10 162 0.6× 55 0.3× 63 0.9× 56 0.9× 40 1.3× 28 269
Mark Becker United States 9 453 1.8× 399 2.2× 53 0.7× 87 1.4× 12 0.4× 10 520
S.F.L. van Lelyveld Netherlands 13 255 1.0× 234 1.3× 107 1.4× 111 1.8× 6 0.2× 28 395
José M. Miró Spain 11 271 1.1× 178 1.0× 94 1.3× 61 1.0× 20 0.6× 21 310
Corine Chazallon France 6 284 1.1× 214 1.2× 53 0.7× 79 1.3× 6 0.2× 12 320
Nanci Hawley‐Foss Canada 10 298 1.2× 341 1.9× 160 2.2× 59 0.9× 45 1.5× 19 588
Anouk M Kesselring Netherlands 6 249 1.0× 220 1.2× 76 1.0× 112 1.8× 7 0.2× 6 308
Margherita Bracchi United Kingdom 7 187 0.7× 126 0.7× 98 1.3× 75 1.2× 4 0.1× 25 268
Antonio Antela Spain 8 300 1.2× 214 1.2× 57 0.8× 98 1.6× 4 0.1× 22 353
Joel E. Gallant United States 6 173 0.7× 95 0.5× 157 2.1× 13 0.2× 13 0.4× 8 282

Countries citing papers authored by Eugénio Teófilo

Since Specialization
Citations

This map shows the geographic impact of Eugénio Teófilo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugénio Teófilo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugénio Teófilo more than expected).

Fields of papers citing papers by Eugénio Teófilo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugénio Teófilo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugénio Teófilo. The network helps show where Eugénio Teófilo may publish in the future.

Co-authorship network of co-authors of Eugénio Teófilo

This figure shows the co-authorship network connecting the top 25 collaborators of Eugénio Teófilo. A scholar is included among the top collaborators of Eugénio Teófilo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugénio Teófilo. Eugénio Teófilo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levett, Tom, Jaime H. Vera, Christopher I. Jones, et al.. (2022). A cross‐sectional assessment of frailty, falls and perceptions of ageing in people living withHIVusing anmHealthplatform. HIV Medicine. 24(4). 431–441. 3 indexed citations
2.
3.
Mandalia, S, et al.. (2020). Ensuring continuity of care for people living with HIV in five European countries: the efficiency of the EmERGE platform. Journal of the International AIDS Society. 23. 99–100. 1 indexed citations
4.
Levett, Tom, Jaime H. Vera, Stephen Bremner, et al.. (2020). Falls and frailty are associated with negative perceived ageing and lower quality of life in people living with HIV using the EmERGE mHealth platform. Figshare. 2 indexed citations
5.
Curran, Adrián, Christian Verger, Eugénio Teófilo, et al.. (2019). «Moving Fourth»: A Vision Toward Achieving Healthy Living with HIV Beyond Viral Suppression. PubMed. 21(3). 135–142. 10 indexed citations
6.
Teófilo, Eugénio, Birger Kuhlmann, Antonio Antela, et al.. (2016). Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study. HIV Clinical Trials. 17(1). 17–28. 2 indexed citations
7.
Casal, Diogo, et al.. (2016). HIV-Associated Facial Lipodystrophy: Experience of a Tertiary Referral Center With Fat and Dermis-Fat Compound Graft Transfer.. PubMed. 16. e31–e31. 4 indexed citations
8.
Perelman, Julian, Joana Alves, Céu Mateus, et al.. (2013). Direct treatment costs of HIV/AIDS in Portugal. Revista de Saúde Pública. 47(5). 865–872. 8 indexed citations
9.
10.
Gouveia, Miguel, et al.. (2012). Budget impact analysis of introducing the new single‐tablet regimen rilpivirine/emtricitabine/tenofovir for the treatment of HIV in Portugal. Journal of the International AIDS Society. 15(S4). 1–1. 1 indexed citations
11.
12.
Camacho, Ricardo & Eugénio Teófilo. (2011). Antiretroviral therapy in treatment-naïve patients with HIV infection. Current Opinion in HIV and AIDS. 6. S3–S11. 22 indexed citations
13.
Teófilo, Eugénio, et al.. (2010). Epithelioid Angiosarcoma in a Patient with Klippel-Trénaunay-Weber Syndrome: An Unexpected Response to Therapy. Case Reports in Oncology. 3(2). 148–153. 10 indexed citations
14.
Doroana, Manuela, et al.. (2010). Portuguese cohort: raltegravir with optimized background therapy (OBT) in multiple‐experienced HIV1‐ and HIV2‐infected patients. Journal of the International AIDS Society. 13(S4). 1 indexed citations
15.
16.
Camacho, R, Koen Deforche, Kristel Van Laethem, et al.. (2004). Nelfinavir resistance in HIV-1 subtype B and G infected patients: evidence for different pathways and novel mutations associated with failure of nelfinavir based regimens. Antiviral Therapy. 9(4). 3 indexed citations
17.
DeJesus, Edwin, Eugénio Teófilo, Jan Gerstoft, et al.. (2004). Abacavir versus Zidovudine Combined with Lamivudine and Efavirenz, for the Treatment of Antiretroviral‐Naive HIV‐Infected Adults. Clinical Infectious Diseases. 39(7). 1038–1046. 175 indexed citations
18.
19.
Wood, Robin, Keikawus Arastéh, Hans‐Jürgen Stellbrink, et al.. (2003). Six-Week Randomized Controlled Trial To Compare the Tolerabilities, Pharmacokinetics, and Antiviral Activities of GW433908 and Amprenavir in Human Immunodeficiency Virus Type 1-Infected Patients. Antimicrobial Agents and Chemotherapy. 48(1). 116–123. 36 indexed citations
20.
Teófilo, Eugénio, et al.. (1998). Progressive multifocal leukoencephalopathy regression with highly active antiretroviral therapy.. PubMed. 12(4). 449–449. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cassidy Henegar Breakdown of academic impact, for papers by Mark Becker Breakdown of academic impact, for papers by S.F.L. van Lelyveld Breakdown of academic impact, for papers by José M. Miró Breakdown of academic impact, for papers by Corine Chazallon Breakdown of academic impact, for papers by Nanci Hawley‐Foss Breakdown of academic impact, for papers by Anouk M Kesselring Breakdown of academic impact, for papers by Margherita Bracchi Breakdown of academic impact, for papers by Antonio Antela Breakdown of academic impact, for papers by Joel E. Gallant
Rankless by CCL
2026